Leukemia Research
The presence of additional cytogenetic aberrations in chronic myeloid leukemia cells at the time of diagnosis or their appearance on tyrosine kinase inhibitor therapy predicts the imatinib treatment failure
Publication date: Available online 28 June 2023Source: Leukemia ResearchAuthor(s): Błażej Ratajczak, Anna Przybyłowicz-Chalecka, Joanna Czerwińska-Rybak, Zuzanna Kanduła, Adam Ustaszewski, Lidia Gil, Krzysztof Lewandowski, Małgorzata Jarmuż-Szymczak…